Home/Filings/4/0001683168-17-000824
4//SEC Filing

Sonoma Pharmaceuticals, Inc. 4

Accession 0001683168-17-000824

$SNOACIK 0001367083operating

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 5:16 PM ET

Size

5.7 KB

Accession

0001683168-17-000824

Insider Transaction Report

Form 4
Period: 2017-04-03
Umscheid Marc
Chief Strategy/Mkt Officer
Transactions
  • Award

    Stock option (right to buy)

    2017-04-03+17,00072,000 total
    Exercise: $7.06Exp: 2027-04-03Common Stock (17,000 underlying)
Footnotes (2)
  • [F1]The stock options vest in three years with the first one-third vesting on the first anniversary of the date of the grant, the second one-third vesting on the second anniversary of the date of the grant and the remainder vesting on the third anniversary of the date of the grant.
  • [F2]The stock options were granted in connection with Mr. Umscheid's service as the Issuer's Chief Strategy and Chief Marketing Officer.

Issuer

Sonoma Pharmaceuticals, Inc.

CIK 0001367083

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001367083

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:16 PM ET
Size
5.7 KB